Protective Effects of Curcumin on Diabetic Nephropathy Via Attenuation of Kidney Injury Molecule 1 (KIM-1) and Neutrophil Gelatinase-associated Lipocalin (NGAL) Expression and Alleviation of Oxidative Stress in Rats with Type 1 Diabetes

Overview

Journal Iran J Basic Med Sci

Publisher Mashhad University of Medical Sciences

Specialty General Medicine

Date 2019 Jun 7

PMID 31168341

Citations 11

Authors

Hassan Ghasemi

Behzad Einollahi

Nejat Kheiripour

Seyed-Reza Hosseini-Zijoud

Masoumeh Farhadian Nezhad

Affiliations

Soon will be listed here.

Abstract

Objectives: One of the serious complications of Type1 diabetes (T1D) is diabetic nephropathy, which is accompanied with overexpression of kidney injury molecule 1 (KIM-1) and neutrophil gelatinase-associated lipocalin (NGAL) and enhanced oxidative stress. The present study was conducted to examine the protective effect of curcumin on the expression of KIM-1, NGAL genes and oxidative damage in the kidney of T1D rats.

Materials And Methods: Thirty-six adult male rats were divided into 6 groups (n=6). The control and T1D groups received treatment with curcumin or without it (80 and 130 mg/kg, respectively). After 60 days of treatment, using spectrophotometric methods, biochemical factors and oxidative stress markers were measured. Gene expression of KIM-1 and NGAL was evaluated using quantitative PCR. Also, plasma and urine levels of these two proteins were assayed by the ELISA kit.

Results: Diabetes caused a significant increase in the levels of creatinine, FBS, uric acid, urea, and creatinine in the serum, which were attenuated after the administration of curcumin. There was a significant reduction in the values of creatinine, uric acid, and urea in urine in the diabetic group whereas in the rats treated with curcumin, these values were normalized to the normal level (especially in 130 mg/kg). Curcumin administration had a significant role in modulation of serum lipid profile, and it was shown to decrease the kidney and urinary expression levels of KIM-1 and NGAL genes and improve oxidative toxic stress in the kidney tissues.

Conclusion: Curcumin can play a protective role in reducing the unpleasant consequences of diabetic nephropathy.

Citing Articles

Curcumin targets CXCL16-mediated podocyte injury and lipid accumulation in diabetic kidney disease treatment.

Chen Y, Tao J, He Y, Hou X, Fang J, Huang J Arch Pharm Res. 2024; 47(12):924-939.

PMID: 39607647 DOI: 10.1007/s12272-024-01521-1.

Curcumin ameliorates pyroptosis in diabetic seminal vesicles by upregulating TRPV6.

Ni D, Xu J, Liu K, Wu N, You B, Yang B Andrology. 2024; 13(3):624-636.

PMID: 38966878 PMC: 11867926. DOI: 10.1111/andr.13687.

Nephroprotective Effect of Leaf Flavonoid Extracts via KIM-1 and TGF-1β Signaling Pathways in Streptozotocin-Induced Rats.

Ajiboye B, Famusiwa C, Nifemi D, Ayodele B, Akinlolu O, Fatoki T ACS Omega. 2024; 9(17):19334-19344.

PMID: 38708257 PMC: 11064007. DOI: 10.1021/acsomega.4c00254.

Mechanisms and efficacy of traditional Chinese herb monomers in diabetic kidney disease.

Chen X, Li X, Cao B, Chen X, Zhang K, Han F Int Urol Nephrol. 2023; 56(2):571-582.

PMID: 37552392 DOI: 10.1007/s11255-023-03703-0.

Oxidative stress and inflammation in diabetic nephropathy: role of polyphenols.

Jin Q, Liu T, Qiao Y, Liu D, Yang L, Mao H Front Immunol. 2023; 14:1185317.

PMID: 37545494 PMC: 10401049. DOI: 10.3389/fimmu.2023.1185317.

References

Manley S, Stratton I, Cull C, Frighi V, Eeley E, Matthews D . Effects of three months' diet after diagnosis of Type 2 diabetes on plasma lipids and lipoproteins (UKPDS 45). UK Prospective Diabetes Study Group. Diabet Med. 2000; 17(7):518-23. DOI: 10.1046/j.1464-5491.2000.00320.x. View

Flower D . Experimentally determined lipocalin structures. Biochim Biophys Acta. 2000; 1482(1-2):46-56. DOI: 10.1016/s0167-4838(00)00147-3. View

Pfaffl M . A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001; 29(9):e45. PMC: 55695. DOI: 10.1093/nar/29.9.e45. View

Asai A, Miyazawa T . Dietary curcuminoids prevent high-fat diet-induced lipid accumulation in rat liver and epididymal adipose tissue. J Nutr. 2001; 131(11):2932-5. DOI: 10.1093/jn/131.11.2932. View

Brownlee M . Biochemistry and molecular cell biology of diabetic complications. Nature. 2001; 414(6865):813-20. DOI: 10.1038/414813a. View

Arun N, Nalini N . Efficacy of turmeric on blood sugar and polyol pathway in diabetic albino rats. Plant Foods Hum Nutr. 2002; 57(1):41-52. DOI: 10.1023/a:1013106527829. View

Sacks F, Tonkin A, Craven T, Pfeffer M, Shepherd J, Keech A . Coronary heart disease in patients with low LDL-cholesterol: benefit of pravastatin in diabetics and enhanced role for HDL-cholesterol and triglycerides as risk factors. Circulation. 2002; 105(12):1424-8. DOI: 10.1161/01.cir.0000012918.84068.43. View

Kalousova M, Skrha J, Zima T . Advanced glycation end-products and advanced oxidation protein products in patients with diabetes mellitus. Physiol Res. 2003; 51(6):597-604. View

Mishra J, Ma Q, Prada A, Mitsnefes M, Zahedi K, Yang J . Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol. 2003; 14(10):2534-43. DOI: 10.1097/01.asn.0000088027.54400.c6. View

10.

Ziyadeh F . Mediators of diabetic renal disease: the case for tgf-Beta as the major mediator. J Am Soc Nephrol. 2003; 15 Suppl 1:S55-7. DOI: 10.1097/01.asn.0000093460.24823.5b. View

11.

Mishra J, Mori K, Ma Q, Kelly C, Yang J, Mitsnefes M . Amelioration of ischemic acute renal injury by neutrophil gelatinase-associated lipocalin. J Am Soc Nephrol. 2004; 15(12):3073-82. DOI: 10.1097/01.ASN.0000145013.44578.45. View

12.

Erel O . A new automated colorimetric method for measuring total oxidant status. Clin Biochem. 2005; 38(12):1103-11. DOI: 10.1016/j.clinbiochem.2005.08.008. View

13.

Best L, Elliott A, Brown P . Curcumin induces electrical activity in rat pancreatic beta-cells by activating the volume-regulated anion channel. Biochem Pharmacol. 2007; 73(11):1768-75. DOI: 10.1016/j.bcp.2007.02.006. View

14.

Pari L, Murugan P . Antihyperlipidemic effect of curcumin and tetrahydrocurcumin in experimental type 2 diabetic rats. Ren Fail. 2007; 29(7):881-9. DOI: 10.1080/08860220701540326. View

15.

Tang Y, Zheng S, Chen A . Curcumin eliminates leptin's effects on hepatic stellate cell activation via interrupting leptin signaling. Endocrinology. 2009; 150(7):3011-20. PMC: 2703516. DOI: 10.1210/en.2008-1601. View

16.

Na L, Zhang Y, Li Y, Liu L, Li R, Kong T . Curcumin improves insulin resistance in skeletal muscle of rats. Nutr Metab Cardiovasc Dis. 2010; 21(7):526-33. DOI: 10.1016/j.numecd.2009.11.009. View

17.

Nielsen S, Schjoedt K, Astrup A, Tarnow L, Lajer M, Hansen P . Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Kidney Injury Molecule 1 (KIM1) in patients with diabetic nephropathy: a cross-sectional study and the effects of lisinopril. Diabet Med. 2010; 27(10):1144-50. DOI: 10.1111/j.1464-5491.2010.03083.x. View

18.

Alappat L, Awad A . Curcumin and obesity: evidence and mechanisms. Nutr Rev. 2010; 68(12):729-38. DOI: 10.1111/j.1753-4887.2010.00341.x. View

19.

Steck A, Rewers M . Genetics of type 1 diabetes. Clin Chem. 2011; 57(2):176-85. PMC: 4874193. DOI: 10.1373/clinchem.2010.148221. View

20.

Nielsen S, Andersen S, Zdunek D, Hess G, Parving H, Rossing P . Tubular markers do not predict the decline in glomerular filtration rate in type 1 diabetic patients with overt nephropathy. Kidney Int. 2011; 79(10):1113-8. DOI: 10.1038/ki.2010.554. View